HomeInsightsMarket Capitalization

Market Capitalization of Panacea Biotec Ltd

Market Capitalization of Panacea Biotec Ltd

stocks purchased

₹ 4.3 Cr

Volume transacted

stocks purchased

134.9 K

stocks traded

Last Updated time: 13 Sep 15:00 PM

Image

Panacea Biotec Ltd

NSE: PANACEABIO

MARKETCAP

1857.43 crore

Last updated: 12 Sep 24

Key Highlights

  • The Market Cap of Panacea Biotec Ltd is ₹ 1857 crore as of 12 Sep 24.
  • The Market Cap of Panacea Biotec Ltd changed from ₹ 1213 crore on March 2019 to ₹ 663.65 crore on March 2023 . This represents a CAGR of -11.38% over 5 years. .
  • The Latest Trading Price of Panacea Biotec Ltd is ₹ 318.4 as of 13 Sep 14:51.

Historical Market Cap of Panacea Biotec Ltd

No data available

* All values are in crore

Company Fundamentals for Panacea Biotec Ltd

No data available

Image

Panacea Biotec Ltd

NSE: PANACEABIO

PRICE

318.4

15.15 (5.00%)

stock direction

Last updated: 13 Sep 14:51

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Panacea Biotec Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Panacea Biotec Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Panacea Biotec Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Panacea Biotec Ltd01,857
Sun Pharmaceuticals Industries Ltd424,47,464
Divis Laboratories Ltd861,45,517
Cipla Ltd301,33,821
Torrent Pharmaceuticals Ltd701,17,090
Zydus Lifesciences Ltd271,12,713

Key Valuation Metric of Panacea Biotec Ltd

No data available

Historical P/E Ratio of Panacea Biotec Ltd

No data available

* All values are in %

Historical Revenue of Panacea Biotec Ltd

No data available

* All values are in crore

Historical EBITDA of Panacea Biotec Ltd

No data available

* All values are in crore

Historical Net Profit of Panacea Biotec Ltd

No data available

* All values are in crore

Historical Dividend Payout of Panacea Biotec Ltd

No data available

* All values are in %

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on 2nd February 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

Panacea Biotec Ltd News Hub

News

Panacea Biotec announces board meeting date

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 August 2...

Read more

07 Aug 202410:25

News

Panacea Biotec to convene board meeting

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 30 May 2024...

Read more

13 May 202416:31

News

Panacea Biotec schedules board meeting

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 13 February...

Read more

31 Jan 202417:07

News

Gorani Industries schedules board meeting

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 8 February ...

Read more

25 Jan 202410:46

News

Panacea Biotech gains after launching Easyfourpol vaccine in India

EasyFourPol is the world's first fully liquid wP-IPV Pentavalent vaccine. wP-IPV Pentavale...

Read more

15 Dec 202312:57

News

Panacea Biotec announces board meeting date

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 10 November...

Read more

25 Oct 202315:32

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Panacea Biotec Ltd

What is the market cap of Panacea Biotec Ltd?

As of September 13, 2024, Panacea Biotec Ltd has a market capitalization of ₹1857.43, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Panacea Biotec Ltd's market capitalization?

Panacea Biotec Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Panacea Biotec Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Panacea Biotec Ltd's market capitalization change?

Panacea Biotec Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*